OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
38
Results
Show all
Save search
Copy query
Show results for
Unknown
(38)
Publication Date
Release Date
2020
(16)
2024
(4)
2021
(4)
2008
(4)
2022
(3)
2018
(2)
2026
(1)
2025
(1)
2023
(1)
2019
(1)
2017
(1)
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
Counting Caenorhabditis elegans: Protocol Optimization and Applications for Population Growth and Toxicity Studies in Liquid Medium.
Not available
S-EPMC5772475
|
biostudies-literature
Cite
Strategies for robust and accurate experimental approaches to quantify nanomaterial bioaccumulation across a broad range of organisms.
Not available
S-EPMC6774209
|
biostudies-literature
Cite
Risk factors and outcomes for recurrent paediatric in-hospital cardiac arrest: Retrospective multicenter cohort study.
Not available
S-EPMC12448236
|
biostudies-literature
Cite
Cognitive function over time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): results of a randomized, controlled trial of naproxen and celecoxib.
Not available
S-EPMC2925195
|
biostudies-literature
Cite
Efficacy and Safety of Bimagrumab in Sporadic Inclusion Body Myositis: Long-term Extension of RESILIENT.
Not available
S-EPMC8032371
|
biostudies-literature
Cite
Peripheral Vasopressor Use in Early Sepsis-Induced Hypotension.
Not available
S-EPMC12391982
|
biostudies-literature
Cite
Early Restrictive or Liberal Fluid Management for Sepsis-Induced Hypotension.
Not available
S-EPMC10685906
|
biostudies-literature
Cite
Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial.
Not available
S-EPMC9334931
|
biostudies-literature
Cite
A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19.
Not available
S-EPMC7781100
|
biostudies-literature
Cite
Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial.
Not available
S-EPMC8700279
|
biostudies-literature
Cite
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets